ECSP003389A - COMPOUNDS AND PROCEDURES FOR THE TREATMENT OF ASTHMA, ALLERGY AND INFLAMMATORY DISORDERS - Google Patents
COMPOUNDS AND PROCEDURES FOR THE TREATMENT OF ASTHMA, ALLERGY AND INFLAMMATORY DISORDERSInfo
- Publication number
- ECSP003389A ECSP003389A ECSP003389A ECSP003389A EC SP003389 A ECSP003389 A EC SP003389A EC SP003389 A ECSP003389 A EC SP003389A EC SP003389 A ECSP003389 A EC SP003389A
- Authority
- EC
- Ecuador
- Prior art keywords
- compounds
- asthma
- substituted
- rhinitis
- allergy
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 208000006673 asthma Diseases 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 2
- 206010020751 Hypersensitivity Diseases 0.000 title 1
- 208000026935 allergic disease Diseases 0.000 title 1
- 230000007815 allergy Effects 0.000 title 1
- 208000027866 inflammatory disease Diseases 0.000 title 1
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 150000002617 leukotrienes Chemical class 0.000 abstract 2
- 206010039083 rhinitis Diseases 0.000 abstract 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
- 206010010741 Conjunctivitis Diseases 0.000 abstract 1
- 201000004624 Dermatitis Diseases 0.000 abstract 1
- 208000004262 Food Hypersensitivity Diseases 0.000 abstract 1
- 206010016946 Food allergy Diseases 0.000 abstract 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 abstract 1
- 206010033078 Otitis media Diseases 0.000 abstract 1
- 208000005374 Poisoning Diseases 0.000 abstract 1
- 208000003251 Pruritus Diseases 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 206010039085 Rhinitis allergic Diseases 0.000 abstract 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 abstract 1
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- 208000024780 Urticaria Diseases 0.000 abstract 1
- 201000010105 allergic rhinitis Diseases 0.000 abstract 1
- 230000001387 anti-histamine Effects 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- 208000010668 atopic eczema Diseases 0.000 abstract 1
- 230000009977 dual effect Effects 0.000 abstract 1
- 235000020932 food allergy Nutrition 0.000 abstract 1
- 229960001340 histamine Drugs 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 150000004885 piperazines Chemical class 0.000 abstract 1
- 150000003053 piperidines Chemical class 0.000 abstract 1
- 231100000572 poisoning Toxicity 0.000 abstract 1
- 230000000607 poisoning effect Effects 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 230000001932 seasonal effect Effects 0.000 abstract 1
- 201000009890 sinusitis Diseases 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invnción proporciona compuestos de piperazinas 1,4 sustituidas, piperidinas 1,4-sustituidas y 4-alquilidenilpiperidinas 1-sustituidas. Los compuestos de la invención son moléculas suplentes inhibidoras duales teniendo ambos de inhibición de los leucotrienos, asi como propiedades antihistamínicas. Los compuestos de la invención son útiles para tratar trastornos en los que es posible que se presente un componente histamínico y/o leucotrieno. Estos trastornos incluyen preferiblemente asma, rinitis alérgica estacional y permanente, sinusitis, conjuntivitis, alergia a alimentos, intoxicación escombroide, psoriasis, urticaria, prurito, eccema, artritis reumatoide, enfermedad inflamatoria del intestino, enfermedad pulmonar obstructiva crónica, enfermedad trombótica y otitis media. También se proporcionan procedimientos de tratamiento del asma y la rinitis, administrando a un sujeto que lo necesite una cantidad de los compuestos, eficaz para aliviar el asma y la rinitis.The present invention provides compounds of 1,4-substituted piperazines, 1,4-substituted piperidines and 1-substituted 4-alkylidenylpiperidines. The compounds of the invention are dual inhibitory substitute molecules both having leukotriene inhibition as well as antihistamine properties. The compounds of the invention are useful for treating disorders in which a histamine and / or leukotriene component may be present. These disorders preferably include asthma, seasonal and permanent allergic rhinitis, sinusitis, conjunctivitis, food allergy, scombroid poisoning, psoriasis, urticaria, pruritus, eczema, rheumatoid arthritis, inflammatory bowel disease, chronic obstructive pulmonary disease, thrombotic disease, and otitis media. Asthma and rhinitis treatment procedures are also provided, administering to a subject in need an amount of the compounds effective in alleviating asthma and rhinitis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003389 ECSP003389A (en) | 2000-03-21 | 2000-03-21 | COMPOUNDS AND PROCEDURES FOR THE TREATMENT OF ASTHMA, ALLERGY AND INFLAMMATORY DISORDERS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003389 ECSP003389A (en) | 2000-03-21 | 2000-03-21 | COMPOUNDS AND PROCEDURES FOR THE TREATMENT OF ASTHMA, ALLERGY AND INFLAMMATORY DISORDERS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP003389A true ECSP003389A (en) | 2000-07-21 |
Family
ID=42041019
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP003389 ECSP003389A (en) | 2000-03-21 | 2000-03-21 | COMPOUNDS AND PROCEDURES FOR THE TREATMENT OF ASTHMA, ALLERGY AND INFLAMMATORY DISORDERS |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP003389A (en) |
-
2000
- 2000-03-21 EC ECSP003389 patent/ECSP003389A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JO2250B1 (en) | Compounds and methods for treating of asthma allergy and inflammatory disorders | |
| NO20053242L (en) | 4-substituted benzimidazoles and their use as inhibitors of gastric secretion | |
| EA200970883A1 (en) | INDOLKARBOXAMIDES AS IKK2 INHIBITORS | |
| NO963746D0 (en) | Isoxaline compounds as inhibitors of TNF release | |
| UA95950C2 (en) | 2,6-substituted-4-monosubstituted amino-pyrimidineasprostaglandin d2 receptor antagonists | |
| BRPI0517211A (en) | heterocyclic compound, pharmaceutical composition, its use and process for the preparation of a heterocyclic compound | |
| WO2004085401A8 (en) | 1,2,4-substituted 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity | |
| CY1108252T1 (en) | USE OF Methylene Amide Derivatives in Cardiovascular Disorders | |
| ATE530540T1 (en) | PYRIMIDONE COMPOUNDS AS GSK-3 INHIBITORS | |
| NO20074634L (en) | Substituted heterocycles and their use as CHK1, PDK1 and PAK inhibitors | |
| DE602004005033D1 (en) | BENZAMIDINHIBITORS OF THE P2X7 RECEPTOR | |
| DE602007008723D1 (en) | SELECTIVE ROCK PROTEIN KINASE INHIBITOR AND ITS USE | |
| TW200700415A (en) | New salt and polymorphs of the dpp-iv inhibitor | |
| EA201070779A1 (en) | TRIAZOLE-CONTAINING OXADIAZOLE DERIVATIVES | |
| TW200639151A (en) | 2-phenyl-indoles as prostaglandin D2 receptor antagonists | |
| NO20073941L (en) | Dihydroimidazotiazolderivater | |
| DE60204463D1 (en) | Substituted 8-arylquinolines as PDE4 inhibitors | |
| WO2007102883A3 (en) | Chemical compounds | |
| WO2008011113A3 (en) | Thiadiazolidinone derivatives | |
| ECSP003389A (en) | COMPOUNDS AND PROCEDURES FOR THE TREATMENT OF ASTHMA, ALLERGY AND INFLAMMATORY DISORDERS | |
| CO6230987A2 (en) | SOLID FORMS OF A RAF CINASA INHIBITOR | |
| WO2004072029A3 (en) | Pyrazolopyridazines useful as inhibitors of protein kinases | |
| WO2007062318A3 (en) | Chemical compounds | |
| NO20054199L (en) | 6-substituted imidazopyrazines | |
| TW200616971A (en) | Condensed tricyclic benzimidazoles |